Fortress Biotech, Inc.

US$1.85As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FBIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (25.58%)
Div yield —
ROE 115.99%
Biotechnology
Beta (5Y) 1.26
PE TTM 0.569
TSR TTM (27.73%)
Mkt cap US$61.70M
ROIC (45.52%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.39
29.15%
5.05%
Hold 5|0|4|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.04
0.03
15.03%
4.09%
16.60%
8.74%
Revenue$M
6.941
6.771
6.812
6.757
7.00%
3.12%
(0.61%)
(4.40%)
Peers (US$61.70M)
Cap (US$)
PE
61.95M
—
61.82M
—
Capital
TTM
5Y
10Y
Leveragex
2.512
(0.030)
(0.030)
EBIT/Intx
0.243
0.108
0.111
Own earn%
(362.70)
20.23
27.03
Sh yield%
37.63
46.40
46.66
Owners
Insiders/Inst%
8.85
74.43
Short interest%
5.35
SBC / revenue%
1.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
14–20
$1 testx
0.0
Incr. ROIC%
145